Skip to main content
Novartis
language-selector-globe United States | en
Choose Location
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | Español
Brazil | Português
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Mexico | Español
United States | English
Australia | English
Bangladesh | English
Hong Kong S.A.R. | 繁體中文
India | English
Indonesia | English
Japan | 日本語
Korea | 한국어
Mainland China | 中文
Malaysia | English
Pakistan | English
Philippines | English
Singapore | English
Taiwan | 繁體中文
Thailand | ภาษาไทย
Austria | Deutsch
Belgium | Français
Belgium | Nederlands
Bulgaria | Български
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hungary | Magyar
Ireland | English
Italy | Italiano
Latvia | Latvian
Lithuania | Lithuanian
Netherlands | Nederlands
Norway | Norsk
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Serbia | Srpski
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Türkiye | Türkçe
United Kingdom | English
Global | English
Novartis Foundation | English
Egypt | English
Israel | עברית
Saudi Arabia | العربية
South Africa | English
language-selector-globe us
Choose Location
Americas Asia Pacific Europe International Middle East & Africa
Argentina | Español
Australia | English
Austria | Deutsch
Bangladesh | English
Belgium | Français
Belgium | Nederlands
Brazil | Português
Bulgaria | Български
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Egypt | English
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hong Kong S.A.R. | 繁體中文
Hungary | Magyar
India | English
Indonesia | English
Ireland | English
Israel | עברית
Italy | Italiano
Japan | 日本語
Korea | 한국어
Latvia | Latvian
Lithuania | Lithuanian
Mainland China | 中文
Malaysia | English
Mexico | Español
Netherlands | Nederlands
Norway | Norsk
Global | English
Novartis Foundation | English
Pakistan | English
Philippines | English
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Saudi Arabia | العربية
Serbia | Srpski
Singapore | English
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
South Africa | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Taiwan | 繁體中文
Thailand | ภาษาไทย
Türkiye | Türkçe
United Kingdom | English
United States | English
    • About 
      • Novartis in the US 
        • Diversity equity & inclusion  
        • Pay transparency-EPIC 
        • Our code of ethics 
      • Diversity, equity & inclusion  
        • Novartis US EEO / D&I report 2021 
        • Supplier diversity 
      • People and culture 
      • Products 
      • US Country Coordinating Committee 
      • External funding 
      • Contact us 
      Team meeting About
    • Patients and caregivers 
      • Novartis commitment to patients and caregivers 
      • Patient assistance 
      • Diseases 
        • Chronic spontaneous urticaria (CSU) 
        • Hidradenitis suppurativa (HS) 
        • Prostate Cancer (PC) 
        • Paroxysmal Nocturnal Hemoglobinuria (PNH) 
      • Participating in clinical trials 
      • Patient perspectives 
      • Adverse event reporting 
      • The STEP program 
        • Sickle cell disease (SCD) 
        • Program overview 
        • Multiple sclerosis (MS) 
        • Cancer 
        • Application for funding to help address health disparities 
        • Health disparities 
      • Patient resources 
      Patient smiling at doctor image Patients and caregivers
    • Healthcare professionals 
      • Novartis pipeline 
      • Novartis clinical trials 
      • Adverse event reporting 
      • HCP resources 
      • Personalized and Precision Medicine 
      • Health Information Technology Resources 
      Two doctors examining X-ray Healthcare professionals
    • ESG 
      • Ethical behavior 
        • Code of ethics 
        • SpeakUp 
        • PhRMA Code on interactions with healthcare professionals 
        • Business principles 
      • Ethics, risk and compliance 
        • Compliance program 
        • State laws 
        • Corporate integrity agreement 
        • Payments to HCPs & HCOs 
        • Drug Supply Chain Security Act Information 
      • Corporate responsibility 
        • Population health 
        • Novartis in society US reports 
        • Novartis US Foundation 
        • Environmental sustainability 
        • People and communities 
      • Beacon of hope 
        • Beacon of hope: Measurable solutions for health equity 
        • Paving the way for a brighter, more equitable future 
      Novartis East Hanover Campus Landscaping ESG
    • News 
      • News archive 
      • Statements 
      • Stories 
      • Contacts 
      Co-workers having a meeting News
    • Careers 
      • Career search 
      • Meet the teams 
      • Early career 
      • Personal growth 
      • How we work 
      • Employee benefits 
      • Diversity, equity & inclusion 
      • Awards & recognition 
      Meeting in Atrium Careers
    Grandmother, mother and daughter smiling and laughing on a beach Home
  1. Home
  2. Careers
  3. Career Search
  • Sort by Sort ascending
  • Job Title Sort ascending
  • Site
  • Location
  • Division
  • Business
  • Functional Area
  • Date Posted
Job Title Sort ascending Site Location Division Business Functional Area Date Posted
NCQ QA Manager Taipei Taiwan Operations Innovative Medicines Quality Oct 20, 2024
International Trade Expert ( Customs & Trade Compliance) Basel (City) Switzerland Operations Innovative Medicines Technical Operations Oct 20, 2024
Field Product Specialist - Cardivovascular - HCM Vietnam Vietnam International Innovative Medicines Sales Oct 20, 2024
Field Product Specialist - Cardiovascular- Ha Noi Vietnam Vietnam International Innovative Medicines Sales Oct 20, 2024
Senior Patient Safety Specialist Seoul South Korea Development Innovative Medicines Research & Development Oct 20, 2024
Lead/Associate, CX Content Creation Head Office (Japan) (Pharmaceuticals) Japan International Innovative Medicines Marketing Oct 20, 2024
Specialist za analitiko v Centru za testiranje surovin (m/ž/d) Ljubljana Slovenia Operations Innovative Medicines Quality Oct 20, 2024
Clinical Label Manager Hyderabad (Office) India Development Innovative Medicines Research & Development Oct 20, 2024
Laboratorijski analitik v medfazni analitiki (m/ž/d) Mengeš Slovenia Operations Innovative Medicines Quality Oct 20, 2024
SSO Finance Specialist Shanghai (Shanghai) China Development Innovative Medicines Research & Development Oct 20, 2024
(高级)医药代表 /(资深)产品专员 Ningbo (Zhejiang Province) China International Innovative Medicines Sales Oct 20, 2024
(高级)地区经理 Shenzhen (Guangdong Province) China International Innovative Medicines Sales Oct 20, 2024
Equipment Specialist (m/w/d), Kundl, Tirol, Österreich Kundl Austria Operations Innovative Medicines Technical Operations Oct 18, 2024
Trainee Marketing (m/w/d) Nuremberg (Non-Sales Force) (Novartis Pharma GmbH) Germany International Innovative Medicines Marketing Oct 18, 2024
Schichtführer (m/w/d), Kundl, Tirol, Österreich Kundl Austria Operations Innovative Medicines Technical Operations Oct 18, 2024
Quality Control Staff Sasayama Japan Operations Innovative Medicines Quality Oct 18, 2024
Sales Representative Onkologie (d/w/m), Gebiet: Bremen Bremen (Novartis Pharma GmbH) Germany International Innovative Medicines Sales Oct 18, 2024
Process Expert (m/f/d) – Part-time (50%) Schaftenau Austria Operations Innovative Medicines Technical Operations Oct 18, 2024
Medical Scientific Liaison Manager, Immunologie (w/m/d), Gebiet: Sachsen Saxony (with Corpus Christi) (Novartis Pharma GmbH) Germany International Innovative Medicines Research & Development Oct 18, 2024
Quality Control Staff Sasayama Japan Operations Innovative Medicines Quality Oct 18, 2024
Produktionsmitarbeiter (m/f/d), Kundl, Tirol, Austria Kundl Austria Operations Innovative Medicines Technical Operations Oct 18, 2024
IT Senior Project Manager Barcelona Gran Vía Spain Operations CTS Technology Transformation Oct 18, 2024
Medical Advisor, Ophtha Shanghai (Shanghai) China International Innovative Medicines Research & Development Oct 18, 2024
Medical Advisor, HEMA Shanghai (Shanghai) China International Innovative Medicines Research & Development Oct 18, 2024
Director of Global & Swiss Media & Editorial Basel (City) Switzerland Corporate CTS Communications & Public Affairs Oct 18, 2024
Sr. Spec. DDIT ISC Gov GxP Assessments Hyderabad (Office) India Operations CTS Technology Transformation Oct 18, 2024
Sr. Spec. DDIT IES Supplier Management Hyderabad (Office) India Operations CTS Information Technology Oct 18, 2024
Produktionsmitarbeiter (m/w/d), Schaftenau, Tirol, Austria Schaftenau Austria Operations Innovative Medicines Technical Operations Oct 18, 2024
Production Technician - CDD / SCL Saint-Cloud France Operations Innovative Medicines Technical Operations Oct 18, 2024
Senior Principal Clinical Data Standards Specialist Mumbai (Office) India Development Innovative Medicines Research & Development Oct 18, 2024
Quality Control Staff Sasayama Japan Operations Innovative Medicines Quality Oct 18, 2024
Record to Report (R2R) Specialist New Cairo Egypt Finance CTS Audit & Finance Oct 18, 2024
Record to Report (R2R) Section Head New Cairo Egypt Finance CTS Audit & Finance Oct 18, 2024
Mechaniker - Abfüllung & Inspektion (m/w/d) Schaftenau Austria Operations Innovative Medicines Technical Operations Oct 18, 2024
Buyer - Corporate Spend Prague Czech Republic Operations CTS Procurement Oct 18, 2024
Buyer - Marketing Prague Czech Republic Operations CTS Procurement Oct 18, 2024
IT Solution Delivery Sr. Manager for Medical Products Barcelona Gran Vía Spain Operations CTS Technology Transformation Oct 18, 2024
Specialist kontrole kakovosti II / Specialist laboratorijske opreme (m/ž/d) , Ljubjana Ljubljana Slovenia Operations Innovative Medicines Quality Oct 18, 2024
Medical Safety and Processes Manager Barcelona Gran Vía Spain Development Innovative Medicines Research & Development Oct 18, 2024
Associate Director Commercial Analytics (Cardiovascular) Distant Employee - Distant Working Arrangement (DWA) (USA) USA US Innovative Medicines Marketing Oct 18, 2024
Medical Education Manager, Breast Cancer Montreal Canada International Innovative Medicines Research & Development Oct 18, 2024
Tehnik v proizvodnji bioloških učinkovin (m/ž/d) Mengeš Slovenia Operations Innovative Medicines Technical Operations Oct 18, 2024
Customer Engagement Manager Croatia Croatia International Innovative Medicines Sales Oct 18, 2024
Production Manager Indianapolis USA Operations Innovative Medicines Technical Operations Oct 18, 2024
ED, Product Strategy Lead - Renal East Hanover USA US Innovative Medicines Marketing Oct 18, 2024
Study Start Up Senior Lead Dublin (Novartis Corporate Center (NOCC)) Ireland Development Innovative Medicines Research & Development Oct 18, 2024
Quality Business Excellence Coordinator INSURGENTES Mexico Operations Innovative Medicines Quality Oct 18, 2024
RA Specialist Croatia Croatia Development Innovative Medicines Research & Development Oct 18, 2024
US Market Access Future Leaders Program East Hanover USA US Innovative Medicines Market Access Oct 18, 2024
Cell Processing Specialist I, PM Shift Morris Plains USA Operations Innovative Medicines Technical Operations Oct 18, 2024

Pagination

  • ‹ Previous page
  • 1
  • …
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • …
  • 42
  • › Next page

Novartis United States

Navigate Novartis
  • Patients & caregivers
  • Healthcare professionals
  • ESG
  • News
  • Careers
Media center
  • News archive
  • Statements
  • Stories
Our portfolio
  • Novartis clinical pipeline
  • Novartis product portfolio
Other Novartis US websites
  • Oncology HCP resources
  • Medical information
  • Global site
Footer Bottom
© 2024 Novartis Pharmaceuticals Corporation
  • Terms of use
  • Privacy policy
  • Consumer health privacy policy
  • Contacts
  • Site map
  • Web accessibility
Novartis Site Directory
This site is intended for US residents only